No. d'articleCNLM-7503-CA
Set Of 4 2′-ribonucleoside 5′-triphosphates (U-¹³C, U-¹⁵N; 98-99%) CP 90% (in solution)
Synonymes
FormuleNA
CAS Nombre LabeledNA
CAS Nombre UnlabeledNA
Numéro CE
No d'article | Package size | Disponibilitée | List Price | Prix | ||
---|---|---|---|---|---|---|
CNLM-7503-CA | 4x100 µmol | Stock bas | $5740 | Prix $5740 |
Propriétés
Molecular WeightNA
Purity90%
FormIndividual
ConcentrationSolution
Application(s)Biomolecular NMR, Genetic Therapy
Storage TempStore in freezer (-20°C). Protect from light.
Description
Description du produit
Set of 4 ribonucleoside triphosphates (U-13C, U-15N, 98%) supplied as the ammonium salt. Contains adenosine 5'-triphosphate, cytidine 5'-triphosphate, guanosine 5'-triphosphate, uridine 5'-triphosphate.
Application(s)
Informations sur la sécurité
Hazard Pictograms
Signal Word
Hazard Statement
Commentaires
Il n'ya pas de commentaires pour le moment.
No. d'articleCNLM-7503-CA
Set Of 4 2′-ribonucleoside 5′-triphosphates (U-¹³C, U-¹⁵N; 98-99%) CP 90% (in solution)
Product is supplied as the ammonium salt at 100mm
(100umol in 1 ml water, ph ~7.5).
Please allow 2-3 weeks for packaging from bulk stock
Note: composed of CNLM-4265-CA, CNLM-4267-CA,
CNLM-4269-CA and CNLM-4271-CA.
Dry ice shipment required.
Synonymes
FormuleNA
CAS Nombre LabeledNA
CAS Nombre UnlabeledNA
Numéro CE
No d'article | Package size | Disponibilitée | List Price | Prix | ||
---|---|---|---|---|---|---|
CNLM-7503-CA | 4x100 µmol | Stock bas | $5740 | Prix $5740 |
Propriétés
Molecular WeightNA
Purity90%
FormIndividual
ConcentrationSolution
Application(s)Biomolecular NMR, Genetic Therapy
Storage TempStore in freezer (-20°C). Protect from light.
Description
Description du produit
Set of 4 ribonucleoside triphosphates (U-13C, U-15N, 98%) supplied as the ammonium salt. Contains adenosine 5'-triphosphate, cytidine 5'-triphosphate, guanosine 5'-triphosphate, uridine 5'-triphosphate.
Application(s)
Informations sur la sécurité
Hazard Pictograms
Signal Word
Hazard Statement
Commentaires
Il n'ya pas de commentaires pour le moment.